MINNEAPOLIS, Aug. 17, 2017 -- The Meritex Company announced today the completion of its Jefferson II Distribution Building, a 57,750-square foot Class A modern industrial facility located in the established Park 100 area of Indianapolis. The newly-completed development is the first small Class A multi-tenant industrial building constructed in the area in more than a decade. Highly flexible, Jefferson II can be leased to a full-building user or divided down to as small as 8,250 square feet, accommodating multiple tenants. The building brings Meritex’s investment in the Indianapolis market to nearly 1.3 million square feet.
|
|||||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/9204350b-4165-4655-8cb9-c470047bf7a9
The Indianapolis market has seen a steadily increasing demand from industrial space users seeking less than 15,000 square feet, yet prior to the completion of Jefferson II, there were no buildings in the area that could meet that need. “We’ve been aware of the growing need for small industrial spaces in the Indianapolis market for quite a while. Jefferson II was specifically designed to be adaptable to tenant needs based on that demand,” says Jill Evans, portfolio manager for Meritex in Indianapolis. Matt Wagner, director of acquisitions states, “We were compelled to move forward with this development on a speculative basis because of the historical low vacancy, attractive rents, and lack of modern small to mid-bay industrial product in Park 100.”
The new development was constructed alongside the Jefferson I Distribution Building, which Meritex acquired in 2012 along with the 4.5 acres of land that Jefferson II now sits on. Jefferson I was built in 2000 and has maintained 100 percent occupancy since Meritex took over its management. Tenants of the building employ nearly 30 people and contain 73,290 square feet of space in a multi-tenant office/warehouse configuration.
The newly completed Jefferson II Distribution Building is located in the popular Park 100 area and offers modern amenities with excellent access. The building is now available for lease and is currently being marketed by JLL.
About The Meritex Company
Meritex is a fourth-generation, private, family-owned real estate and investment company that acquires, develops, owns and operates more than 10 million square feet of commercial real estate. The spaces are primarily institutional grade, multi-tenant industrial properties. Meritex is headquartered in Minneapolis and operates in eight markets -- Atlanta, Charlotte, Columbus, Houston, Indianapolis, Kansas City, Minneapolis-St. Paul and Phoenix.
Contacts: Deb Berger Meritex [email protected] 651-855-9680 Catherine Roman Pineapple RM [email protected] 262-510-5624


Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
Robinhood Expands Sports Event Contracts With Player Performance Wagers
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Shell M&A Chief Exits After BP Takeover Proposal Rejected
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 



